<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160716028948N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-29</date_registration>
      <primary_sponsor>Ghoum University of Medical Sciences</primary_sponsor>
      <public_title>Effect of breathing exercises training in arterial oxygen saturation and anxiety of COVID-19 Patients</public_title>
      <acronym></acronym>
      <scientific_title>Effect of breathing exercises training on arterial oxygen saturation and anxiety in COVID-19 Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60686</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: By referring to the Medical Record Unit of Qom educational hospital, the files of hospitalized COVID-19 patients will be extracted and samples will be selected by simple random sampling (using lottery) based on inclusion criteria.
Then, each person is given a number and based on random numbers table, the subjects will be placed in two groups of control and intervention. In this way, from the table, the two digits on the left side of the number chosen randomly are considered as the number of the person and and patients will be placed in two groups of control and intervention every others.</study_design>
      <phase>N/A</phase>
      <hc_freetext>COVID-19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After completing the written consent by the patients, information is collected from the samples of the intervention and control groups by the Beck Anxiety Inventory and a checklist of clinical data on O2Sat and respiration rate. Then, the training program of breathing exercises runs according to the protocol of breathing exercises and relaxation for the intervention group, during 15-minute daily sessions for four weeks at home and virtually (internal messengers such as Eitaa) through the training content provided by trained experts. The subjects in these sessions receive active coughing exercises (3 sets, 10 repetitions), diaphragmatic breathing and budding lips (30 voluntary breathing in various positions including supine position, prone position, side-lying position, and quadruped position), chest volume-enhancing exercises according to the therapist's instructions (the patient performs horizontal opening, bending, turning and external rotation of the arms at the same time with each breathing cycle) and resistance exercises of the respiratory muscles by the patient himself. These exercises will be in a range of simple to difficult and based on the patient's condition. Also, during these four weeks, the research team will be sure that the intervention protocol movements are performed correctly by the patients. One week after the intervention, the level of anxiety and O2Sat in the hospital will be measured again using a pulse oximetry device and a questionnaire by the same researcher who measured and recorded the outcome variables before the breathing exercises. Intervention 2: Control group: No educational intervention is done on the control group and they are received only usual care. Also, data are collected from the samples of the control group before and one week after the intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Decisions should be made at the university's discretion</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Zahra Taheri-kharameh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Iran, Qom, University Campus, Building No. 1, School of Paramedical Sciences</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>373617-5513</zip>
        <telephone>+98 25 3197 1136</telephone>
        <email>ztaheri@muq.ac.ir</email>
        <affiliation>Ghoum University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Zahra Taheri-kharameh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Iran, Qom, University Campus, Building No. 1, School of Paramedical Sciences</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>37361-75513</zip>
        <telephone>+98 25 3197 1136</telephone>
        <email>ztaheri@muq.ac.ir</email>
        <affiliation>Ghoum University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a minimum Hemoglobin 11 gr/dl
Having body temperature between 36.5°C to 37.5°C
Having minimum systolic blood pressure 100 mmHg
Going through the acute stage of the disease
Having full consciousness and awareness of time, place and person
Having the desire to participate in training
Have not previously received any training on breathing exercises and have not participated in any other training program during this study.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having heart, kidney, liver, gastrointestinal, and peripheral edema problems
Having uncontrolled diabetes and blood pressure
Exacerbation of the disease and death of the patient during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>U07.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>COVID-19,virus identified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After completing the written consent by the patients, information is collected from the samples of the intervention and control groups by the Beck Anxiety Inventory and a checklist of clinical data on O2Sat and respiration rate. Then, the training program of breathing exercises runs according to the protocol of breathing exercises and relaxation for the intervention group, during 15-minute daily sessions for four weeks at home and virtually (internal messengers such as Eitaa) through the training content provided by trained experts. The subjects in these sessions receive active coughing exercises (3 sets, 10 repetitions), diaphragmatic breathing and budding lips (30 voluntary breathing in various positions including supine position, prone position, side-lying position, and quadruped position), chest volume-enhancing exercises according to the therapist's instructions (the patient performs horizontal opening, bending, turning and external rotation of the arms at the same time with each breathing cycle) and resistance exercises of the respiratory muscles by the patient himself. These exercises will be in a range of simple to difficult and based on the patient's condition. Also, during these four weeks, the research team will be sure that the intervention protocol movements are performed correctly by the patients. One week after the intervention, the level of anxiety and O2Sat in the hospital will be measured again using a pulse oximetry device and a questionnaire by the same researcher who measured and recorded the outcome variables before the breathing exercises.</i_keyword>
      <i_keyword>Control group: No educational intervention is done on the control group and they are received only usual care. Also, data are collected from the samples of the control group before and one week after the intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Arterial blood oxygen saturation (O2Sat). Timepoint: The effect of breathing exercises training on Arterial blood oxygen saturation (O2Sat) in Covid-19 patients, before and one week after the intervention. Method of measurement: Arterial blood oxygen saturation (O2Sat) checklist.</prim_outcome>
      <prim_outcome>Respiratory rate (RR). Timepoint: The effect of breathing exercises training on respiratory rate in Covid-19 patients, before and one week after the intervention. Method of measurement: Respiration rate checklist.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: Before and one week after the intervention. Method of measurement: Beck Anxiety Inventory.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ghoum University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-14</approval_date>
        <contact_name>Ethics Committee Qom University of Medical Sciences</contact_name>
        <contact_address>No. 83, alley 4, Jahad daneshgahi street, Safashahr street, Qom, Iran Qom Ghoum Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
